Comparison between 1-year outcomes of aflibercept with and without photodynamic therapy for polypoidal choroidal vasculopathy: Retrospective observation study-Reference-Cited by-同舟云学术

Comparison between 1-year outcomes of aflibercept with and without photodynamic therapy for polypoidal choroidal vasculopathy: Retrospective observation study

Published:2017-05-03 Issue:5 Volume:12 Page:e0176100
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Takayama Kei,Kaneko Hiroki^ORCID,Kataoka Keiko,Hattori Kyoko,Ra Eimei,Tsunekawa Taichi,Fukukita Hiroshi,Haga Fuminori,Ito Yasuki,Terasaki Hiroko

Funder

Grants-in-Aid for Scientific Research B

Grant-in-Aid for Young Scientists B

Chukyo longevity medical and promotion foundation

Takeda Medical Research Foundation

The Hori Science and Arts Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Polypoidal choroidal vasculopathy, diagnosis and management;G Coppens;Bull Soc Belge Ophtalmol,2011

2. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment;AH Koh;Retina,2013

3. Idiopathic polypoidal choroidal vasculopathy (IPCV);LA Yannuzzi;Retina,1990

4. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy;LA Yannuzzi;Arch Ophthalmol,1997

5. Polypoidal choroidal vasculopathy;AP Ciardella;Surv Ophthalmol,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of One-Year Outcome of Intravitreal Aflibercept with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy;Medicina;2024-08-14

2. Photodynamic and Anti-VEGF Therapy for Polypoidal Choroidal Vasculopathy - ‘Real World’ Outcomes in a Caucasian Population;The Open Ophthalmology Journal;2023-03-03

3. Dimethyl Fumarate Protects Retinal Pigment Epithelium from Blue Light-Induced Oxidative Damage via the Nrf2 Pathway;Antioxidants;2022-12-26

4. Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort;Graefe's Archive for Clinical and Experimental Ophthalmology;2022-06-09

5. Macular atrophy at 5 years after photodynamic therapy for polypoidal choroidal vasculopathy;Eye;2022-04-14